0001237899-17-000019.txt : 20170809
0001237899-17-000019.hdr.sgml : 20170809
20170809160352
ACCESSION NUMBER: 0001237899-17-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170807
FILED AS OF DATE: 20170809
DATE AS OF CHANGE: 20170809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 171017850
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9143477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-08-07
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Finance & CFO
Common Stock
2017-08-07
4
M
0
2000
272.7
A
9099
D
Common Stock
2017-08-07
4
F
0
1167
466.98
D
7932
D
Common Stock
2017-08-07
4
F
0
307
466.98
D
7625
D
Common Stock
2017-08-08
4
S
0
100
469.91
D
7525
D
Common Stock
2017-08-08
4
S
0
100
471.0
D
7425
D
Common Stock
2017-08-08
4
S
0
100
472.54
D
7325
D
Common Stock
2017-08-08
4
S
0
226
473.57
D
7099
D
Common Stock
83
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
272.7
2017-08-07
4
M
0
2000
0.0
D
2023-09-09
Common Stock
2000
64000
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 226 shares of Company stock on August 8, 2017 at prices ranging from $473.27 to $472.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2017 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2017-08-09